Bvf Inc Glycomimetics Inc Transaction History
Bvf Inc
- $3.15 Billion
- Q3 2024
A detailed history of Bvf Inc transactions in Glycomimetics Inc stock. As of the latest transaction made, Bvf Inc holds 9,544,262 shares of GLYC stock, worth $2.29 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,544,262
Previous 9,544,262
-0.0%
Holding current value
$2.29 Million
Previous $2.67 Million
39.3%
% of portfolio
0.05%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding GLYC
# of Institutions
36Shares Held
17.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.67MShares$640,8490.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$471,6270.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$187,4640.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$173,5640.0% of portfolio
-
Geode Capital Management, LLC Boston, MA521KShares$125,0930.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $12.6M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...